An overview of the evolution of EV71 vaccine
Li, M.; Yin, Y.; Li, J.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 27(4): 933-936
2010
ISSN/ISBN: 1001-5515 PMID: 20842875 Document Number: 645591
EV71 infection has become a serious public health threat especially among young children. Yet, at present, no specific antiviral drug against EV71 infection is available. A number of scientists are studying various kinds of vaccines, including inactivated vaccine, virus-like particle vaccine, DNA vaccine, synthetic peptide vaccines, and transgenic oral vaccine. This article reviews the recent advancement in the design of various kinds of vaccine against EV71 as well as their prospective usefulness, effectiveness, weakness and developments in the foreground.
Document emailed within 1 workday
Related Documents
Grsković, B.; Mrsić, G. 2010: Y chromosome: from evolution to forensics--an overview Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 64(1): 33-40Wong, J.C.; Ursano, R.J. 1997: Traumatic stress--an overview of diagnostic evolution and clinical treatment Annals of the Academy of Medicine Singapore 26(1): 76-87
Iakovenko, M.L.; Korotkova, E.A. 2008: Evolution of vaccine poliovirus strains Voprosy Virusologii 53(3): 45-48 Following Back Cover
Kasili, E.G. 1993: Evolution of paediatric oncology over the years: overview with a focus on sub-Saharan Africa and examples from the Kenyan experience East African Medical Journal 70(6): 343-347
Rice, C.M. 1990: Overview of flavivirus molecular biology and future vaccine development via recombinant DNA Southeast Asian Journal of Tropical Medicine and Public Health 21(4): 670-677
Perry, H.B.; Zulliger, R.; Rogers, M.M. 2014: Community health workers in low-, middle-, and high-income countries: an overview of their history, recent evolution, and current effectiveness Annual Review of Public Health 35: 399-421
Verminnen, K.; Vanrompay, D. 2009: Chlamydophila psittaci infections in turkeys: overview of economic and zoonotic importance and vaccine development Drugs of Today 45 Suppl B: 147-150
Baxter, J.D. 1991: An overview of twenty years of observation concerning etiology, prevalence, and evolution of otitis media and hearing loss among the Inuit in the eastern Canadian Arctic Arctic medical research Suppl: 616-619
Bennici, A. 2005: A new paradigma on the plant evolution: from a natural evolution to an artificial evolution? Rivista di Biologia 98(1): 39-46
Friedrich, F. 2000: Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus Acta Virologica 44(2): 109-117
Parzefall, J. 1984: Regressive Evolution und Verhalten von Höhlenbewohnern - Evolution régressive et comportement chez les animaux cavernicoles - Regressive evolution and behaviour in cave living animals Zeitschrift für Zoologische Systematik und Evolutionsforschung (3): 26-35
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781
De Silva, A.M.; Harris, E. 2018: Which Dengue Vaccine Approach Is the Most Promising, and Should we be Concerned about Enhanced Disease after Vaccination? the Path to a Dengue Vaccine: Learning from Human Natural Dengue Infection Studies and Vaccine Trials Cold Spring Harbor Perspectives in Biology 10(6)
Yuan, C.D. 1989: Immune response and reactions to simultaneous administration of hepatitis B vaccine with routine vaccine in children. II. Immune response and reactions to simultaneous administration of hepatitis B vaccine with Japanese B encephalitis vaccine and measles vaccine Zhonghua Liu Xing Bing Xue Za Zhi 10(4): 210-214
Akhverdian, V.Z.; Khrenova, E.A.; Lobanov, A.O.; Krylov, V.N. 1998: Role of divergence in evolution of group B3 Pseudomonas aeruginosa transposable phage evolution Genetika 34(6): 846-849
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Townsend, J.S.; Steele, C.Brooke.; Hayes, N.; Bhatt, A.; Moore, A.R. 2017: Human Papillomavirus Vaccine as an Anticancer Vaccine: Collaborative Efforts to Promote Human Papillomavirus Vaccine in the National Comprehensive Cancer Control Program Journal of Women's Health 26(3): 200-206
Lorenzo, N.; Gómez Moreiras, J.J.; Parás Chavero, E. 1974: Acute coronary insufficiency. Delayed evolution and evolution in the hospital Archivos del Instituto de Cardiologia de Mexico 44(6): 824-834